The table below shows Immunome Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$0.00
$0.00
$4.01M
$2.93M
$2.91M
$2.36M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$46.38M
$49.19M
$40.45M
$36.87M
$37.20M
$29.08M
SG&A
IMNM annual revenue (10-K history)
Immunome Inc. reported annual revenue of $6.94M for fiscal year 2025. That is down 23.2% from $9.04M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.